A nanoparticle vaccine for SARS-CoV-2 produces signs of immunity in mice and macaques

(American Association for the Advancement of Science) A new nanoparticle vaccine for SARS-CoV-2, the virus that causes COVID-19, has shown hints of protection and immunity in a preclinical study, safely eliciting the production of antibodies and antiviral T cell responses in mice and pigtail macaques.